Insider · CIK 0001467848

Tambi Brian

Reports to the SEC for 2 companies · LAKE FOREST, IL

sec.gov

Transactions

Companies

Filings

CIK

0001467848

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-05-09	AKORN INCA Award	Director	AAward	+30.8K sh	—	—	96,024
2019-05-09	AKORN INCStock Options (Right to Buy)A Award	Director	AAward	+58.8K sh	—	—	58,775
2018-05-10	Insys Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+33.7K sh	$0.61	+$20.5K	37,654
2018-05-10	Insys Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+68.9K sh	$1.62	+$112K	106,504
2018-05-10	Insys Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+60K sh	$3.63	+$218K	166,504
2018-05-10	Insys Therapeutics, Inc.S Sale	Director	SSale	−167K sh	$6.41	−$1.07M	0
2018-05-10	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−33.7K sh	—	—	0
2018-05-10	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−68.9K sh	—	—	0
2018-05-10	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−60K sh	—	—	0
2018-04-19	AKORN INCA Award	Director	AAward	+14.2K sh	—	—	65,264
2018-02-21	Insys Therapeutics, Inc.A Award	Director	AAward	+4,000 sh	—	—	4,000
2018-02-21	Insys Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−4,000 sh	—	—	0
2017-11-21	AKORN INCS Sale	Director	SSale	−15.1K sh	$33.35	−$504K	51,075
2017-08-04	AKORN INCS Sale	Director	SSale	−5,165 sh	$33.37	−$172K	66,175
2017-05-04	AKORN INCA Award	Director	AAward	+8,088 sh	—	—	71,340
2017-02-21	Insys Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2017-02-21	Insys Therapeutics, Inc.Restricted Stock UnitsA Award	Director	AAward	+4,000 sh	—	—	4,000
2016-07-01	AKORN INCA Award	Director	AAward	+4,661 sh	—	—	63,252
2016-07-01	AKORN INCStock Options (Right to Buy)A Award	Director	AAward	+11.6K sh	—	—	11,602
2016-06-02	AKORN INCM Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$2.61	+$65.3K	58,591
2016-06-02	AKORN INCM Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$6.62	+$166K	83,591
2016-06-02	AKORN INCS Sale	Director	SSale	−25K sh	$30.73	−$768K	58,591
2016-06-02	AKORN INCStock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−25K sh	—	—	0
2016-06-02	AKORN INCStock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−25K sh	—	—	0
2016-05-02	Insys Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2015-05-27	Insys Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,100 sh	$1.22	+$3,782	3,100
2015-05-27	Insys Therapeutics, Inc.S Sale	Director	SSale	−3,100 sh	$60.09	−$186K	0
2015-05-27	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,100 sh	—	—	16,827
2015-05-26	Insys Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,800 sh	$1.22	+$2,196	1,800
2015-05-26	Insys Therapeutics, Inc.S Sale	Director	SSale	−1,800 sh	$60.00	−$108K	0
2015-05-26	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,800 sh	—	—	19,927
2015-05-20	Insys Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,900 sh	$1.22	+$4,758	3,900
2015-05-20	Insys Therapeutics, Inc.S Sale	Director	SSale	−3,900 sh	$60.14	−$235K	0
2015-05-20	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,900 sh	—	—	21,727
2015-05-20	AKORN INCStock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2015-05-20	AKORN INCStock Options (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2015-05-19	Insys Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,200 sh	$1.22	+$1,464	1,200
2015-05-19	Insys Therapeutics, Inc.S Sale	Director	SSale	−1,200 sh	$60.01	−$72K	0
2015-05-19	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,200 sh	—	—	25,627
2015-05-05	Insys Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2014-12-15	AKORN INCS Sale	Director	SSale	−1,200 sh	$41.86	−$50.2K	33,591
2014-09-12	AKORN INCM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$0.94	+$18.8K	48,591
2014-09-12	AKORN INCS Sale	Director	SSale	−13.8K sh	$38.00	−$524K	34,791
2014-09-12	AKORN INCStock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2014-09-05	AKORN INCA Award	Director	AAward	+8,034 sh	$38.16	+$307K	28,591
2014-08-07	Insys Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2014-05-02	AKORN INCStock Options (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2013-05-14	Insys Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2013-05-03	AKORN INCA Award	Director	AAward	+4,557 sh	—	—	19,557
2012-09-12	AKORN INCA Award	Director	AAward	+5,000 sh	—	—	15,000

Recent filings

Accepted (ET)
May 134
Tambi Brian0001144204-19-025736
SEC(opens sec.gov)
May 144
Tambi Brian0001209191-18-029966
SEC(opens sec.gov)
Apr 234
Tambi Brian0001171843-18-002969
SEC(opens sec.gov)
Nov 224
Tambi Brian0001171843-17-007254
SEC(opens sec.gov)
Aug 94
Tambi Brian0001171843-17-004905
SEC(opens sec.gov)
May 54
AKORN INC0001171843-17-002744
SEC(opens sec.gov)
Feb 234
Insys Therapeutics, Inc.0001209191-17-014095
SEC(opens sec.gov)
Jul 64
AKORN INC0001171843-16-011004
SEC(opens sec.gov)
Jun 64
AKORN INC0001171843-16-010511
SEC(opens sec.gov)

Companies

Address

1925 W FIELD COURT SUITE 300

LAKE FOREST, IL, 60045